BioSpace News Archive

Drug Development

Biopharma Update on the Novel Coronavirus: December 15

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for December 15, 2020.

December 15, 2020
·
3 min read
·
BioSpace Editorial Staff
Drug Development

Moderna’s FDA COVID-19 Vaccine Adcom is Thursday, and Expectations are High

All eyes are turning to Moderna, which has a meeting with the U.S. Food and Drug Administration (FDA)’s Vaccines and Related Biological Products Advisory Committee on Thursday, December 17. The agency released the data application today.

December 15, 2020
·
6 min read
·
Mark Terry
Drug Development

FDA Pushes Pause on 2 Regeneron Lymphoma Trials for Cytokine Release Syndrome

Regeneron Pharmaceuticals reported that it is pausing enrollment in two of its clinical trials for odronextamab for lymphoma. The U.S. Food and Drug Administration (FDA) placed a partial clinical hold on the trials.

December 15, 2020
·
3 min read
·
Mark Terry
Business

Difficult Decisions, Strategic Streamlining Lead to Workforce Reductions

Mergers and acquisitions are a well-known fact in the life sciences industry, and anyone working within the sector knows to expect them at any time.

December 15, 2020
·
4 min read
·
Heather McKenzie
Pitchbook Report: 2021 Projected to be Another Blockbuster Year for Biopharma VC

One of the key projections is that for the second consecutive year, biotech and pharma VC deal activity will probably exceed $20 billion.

December 15, 2020
·
3 min read
·
Mark Terry
Business

Allogene, Overland Form Joint Venture to Advance Allogenic CAR T Cell Therapies in China

Clinical-stage biotechnology company Allogene Therapeutics and start-up company Overland Pharmaceuticals are forming a new joint company named Allogene Overland Biopharm.

December 15, 2020
·
2 min read
·
Brandon May
Drug Development

Novartis’ KESTREL Study Reaffirms Positive Results of Beovu in DME

On Tuesday, Novartis announced the first interpretable results from its Phase III KESTREL study of humanized single-chain antibody fragment (scFv) Beovu, demonstrating significant improvement in central subfield thickness in Diabetic Macular Edema.

December 15, 2020
·
2 min read
·
Heather McKenzie
Deals

Eli Lilly Snaps Up Gene Therapy Company Prevail Therapeutics in $1.04 Billion Deal

Shares of Prevail Therapeutics have skyrocketed more than 84% in premarket trading after Eli Lilly announced it was acquiring the gene therapy company in a deal valued at approximately $1.04 billion.

December 15, 2020
·
3 min read
·
Alex Keown
BioMidwest

AbbVie Snatches Up Antibody from Harbour BioMed to Fight COVID-19 and Related Mutations

Harbour BioMed (HBM) announced with Utrecht University on Monday that they have licensed their fully human SARS-CoV-2 neutralizing antibody, 47D11, and its program to AbbVie.

December 15, 2020
·
3 min read
·
Krystle Vermes
Biotech Beach

$500M Fund Launches to Bolster LA Life Science Industry

Westlake Village BioPartners launched two new funds totaling $500 million that will be used to build and invest in promising life sciences companies, with a particular focus on bolstering companies in the Los Angeles area.

December 15, 2020
·
2 min read
·
Alex Keown